A major daily newspaper in Berlin, Germany, the “Berliner Zeitung”, reports on its homepage about MucosaTec winning the Innovation Award 2024. The BioRegions prize is awarded for outstanding research results and inventions with high innovation potential. MucosaTec’s technology comprises novel bifunctional peptides that provide a flexible and cost-effective method of combating viral infections.